Renal insufficiency Trials in San Antonio, United States
Conditions / Renal insufficiency / San Antonio, United States
Renal insufficiency has been the subject of sustained clinical investigation across multiple research sites.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01164501 | Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment | COMPLETED | PHASE3 |
| NCT00744939 | Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist | COMPLETED | — |
| NCT00358046 | Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia | UNKNOWN | PHASE2 |
| NCT00770081 | Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study) | COMPLETED | PHASE3 |
| NCT03095391 | The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FAST PV and mGFR Technology™ | COMPLETED | — |
| NCT01407874 | A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency | COMPLETED | PHASE2 |
| NCT00709865 | Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency | COMPLETED | PHASE3 |
| NCT05624710 | A Study to Evaluate the Pharmacokinetics and Safety of INCB054707 in Participants With Normal Hepatic Function and Participants With Hepatic Impairment | COMPLETED | PHASE1 |
| NCT01467271 | Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem Administration | COMPLETED | — |
| NCT01524276 | Product Surveillance Registry | RECRUITING | — |